Transthyretin cardiac amyloidosis
Aldostefano Porcari(University of Trieste), Julian D. Gillmore(Alnylam Pharmaceuticals (United States)), Marianna Fontana(Johnson & Johnson (United States))
Cited by 163
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2021|1.1k
Systemic amyloidosis
|The Lancet|2015|984
A new staging system for cardiac transthyretin amyloidosis
|European Heart Journal|2017|740
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
|New England Journal of Medicine|2002|686